According to Ionis Pharmaceuticals
's latest financial reports the company has $2.33 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $2.33 B | 17.33% |
2022-12-31 | $1.98 B | -6.06% |
2021-12-31 | $2.11 B | 11.76% |
2020-12-31 | $1.89 B | -24.29% |
2019-12-31 | $2.49 B | 19.94% |
2018-12-31 | $2.08 B | 103.78% |
2017-12-31 | $1.02 B | 53.74% |
2016-12-31 | $0.66 B | -17.26% |
2015-12-31 | $0.80 B | -0.83% |
2014-12-31 | $0.81 B | 14.37% |
2013-12-31 | $0.70 B | 73.71% |
2012-12-31 | $0.40 B | 18.74% |
2011-12-31 | $0.34 B | -27.24% |
2010-12-31 | $0.47 B | -17.75% |
2009-12-31 | $0.57 B | 16.97% |
2008-12-31 | $0.49 B | 153.46% |
2007-12-31 | $0.19 B | 0.2% |
2006-12-31 | $0.19 B | 104.83% |
2005-12-31 | $94.38 M | -9.14% |
2004-12-31 | $0.10 B | -51.8% |
2003-12-31 | $0.21 B | -25.52% |
2002-12-31 | $0.28 B | -7.26% |
2001-12-31 | $0.31 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.13 M | -99.99% | Bahamas |
NRC Health
NRC | $6.65 M | -99.71% | ๐บ๐ธ USA |